Abstract Nanotechnology has emerged as a transformative paradigm in modern pharmaceutical sciences, particularly in the design of advanced drug delivery systems capable of precise targeting and controlled therapeutic release. Traditional drug delivery approaches often suffer from limitations such as poor bioavailability, systemic toxicity, rapid drug degradation, and non-specific distribution in [...]

Abstract Digital therapeutics (DTx) represent a rapidly emerging category of medical interventions that utilize evidence-based software programs to prevent, manage, or treat diseases. These technologies operate at the intersection of software engineering, clinical medicine, and behavioral pharmacology, offering novel approaches to therapeutic intervention that extend beyond conventional pharmacological treatments. Advances [...]

Abstract Rapid advances in biotechnology, genomics, and precision medicine have transformed the pharmaceutical innovation landscape, creating unprecedented opportunities for developing novel therapies such as gene therapies, cell-based treatments, RNA therapeutics, and personalized medicines. However, these scientific breakthroughs challenge traditional drug regulatory frameworks that were designed for conventional small-molecule pharmaceuticals. In [...]